Day: September 3, 2025

In August 2025, AS Tallink Grupp transported 595,529 passengers, which is a 5.9% increase compared to August 2024. The number of cargo units decreased by 11.1% to 19,518 units and the number of passenger vehicles increased by 4.7% to 83,569 units compared to the same period a year ago. AS Tallink Grupp passenger, cargo unit and passenger vehicle numbers for August 2025 were the following:  August 2025 August 2024 ChangePassengers 595 529 562 451 5.9%Finland – Sweden 132 285 134 051 -1.3%Estonia – Finland 401 818 347 287 15.7%Estonia – Sweden 61 426 81 113 -24.3%       Cargo Units 19 518 21 953 -11.1%Finland – Sweden 2 569 3 208 -19.9%Estonia – Finland 14 239 15 806 -9.9%Estonia – Sweden 2 710 2 939 -7.8%       Passenger Vehicles 83 569 79 791 4.7%Finland –...

In August 2025, AS Tallink Grupp transported 595,529 passengers, which is a 5.9% increase compared to August 2024. The number of cargo units decreased by 11.1% to 19,518 units and the number of passenger vehicles increased by 4.7% to 83,569 units compared to the same period a year ago. AS Tallink Grupp passenger, cargo unit and passenger vehicle numbers for August 2025 were the following:  August 2025 August 2024 ChangePassengers 595 529 562 451 5.9%Finland – Sweden 132 285 134 051 -1.3%Estonia – Finland 401 818 347 287 15.7%Estonia – Sweden 61 426 81 113 -24.3%       Cargo Units 19 518 21 953 -11.1%Finland – Sweden 2 569 3 208 -19.9%Estonia – Finland 14 239 15 806 -9.9%Estonia – Sweden 2 710 2 939 -7.8%       Passenger Vehicles 83 569 79 791 4.7%Finland –...

Elis announces a 2025 “Elis for All” employee share ownership plan Saint-Cloud, 3 September 2025 – Elis announces the launch of a new “Elis for All” 2025 employee share ownership plan. I. ISSUER ELIS         Euronext Paris regulated market (France) ISIN code for ordinary shares: FR0012435121 Share admitted to the Differed Settlement System (SRD)  II. FRAMEWORK OF THE ISSUANCE – PURPOSE OF THE OFFERING Pursuant to the delegations granted in accordance with the 27th resolution of the Extraordinary General Assembly dated 23 May 2024 and the 25th resolution of the Extraordinary General Assembly dated 22 May 2025, the Management Board, duly authorized by the Supervisory Board on 17 December 2024 confirmed on 30 July 2025, decided on 31 July 2025 to increase the Company’s share capital through two issuances of shares, with no preferential subscription...

Press Release dsm-firmenich achieves target of 100% purchased renewable electricity  Kaiseraugst (Switzerland), Maastricht (Netherlands), September 3, 2025 dsm-firmenich, innovators in nutrition, health, and beauty, today announces that it has achieved its 2025 goal of sourcing 100% of purchased electricity from renewable sources, several months ahead of target. This marks a milestone in the company’s strategy to reach net-zero greenhouse gas (GHG) emissions across its operations and value chain by 2045, as validated by the Science Based Targets initiative (SBTi). These targets include increasing annual sourcing of purchased renewable electricity to 100% by 2025, which has now already been achieved, and maintaining that level through 2030. Dimitri de Vreeze, CEO, commented: “At dsm-firmenich, sustainability lives at the heart of what we...

Faraday Future Launches FX Super One National Co-Creation and Sales Events with Positive Response in New York, Boston, and Los AngelesFX recently held an event in Boston, MA., where guests experienced the FX Super One MPV.Faraday Future Launches FX Super One National Co-Creation and Sales Events with Positive Response in New York, Boston, and Los AngelesFX recently held an event in Boston, MA., where guests experienced the FX Super One MPV.LOS ANGELES, Sept. 02, 2025 (GLOBE NEWSWIRE) — Faraday Future Intelligent Electric Inc. (Nasdaq: FFAI) (“FF”, “Faraday Future”, or the “Company”), a California-based global shared intelligent electric mobility ecosystem company, today announced the conclusion of its FX Super One Co-Creation and sales events in New York, Boston, and Los Angeles....

GUANGZHOU, China, Sept. 03, 2025 (GLOBE NEWSWIRE) — WeRide (Nasdaq: WRD), a global leader in autonomous driving technology, announced today that the Company’s management will participate in the following upcoming investor conferences:Goldman Sachs Asia Leaders Conference in Hong Kong on September 3, 2025 BofA Asia Pacific Conference in Hong Kong on September 8, 2025 CLSA 32nd Investors’ Forum 2025 in Hong Kong on September 9, 2025 Goldman Sachs Communacopia + Technology Conference 2025 in San Francisco on September 11, 2025 BofA Future Car Conference, virtual, on September 24, 2025 Morgan Stanley Asia BEST Corporate Day in New York on September 24, 2025 Evercore ISI Autonomous, ADAS, AI Forum in New York on September 30, 2025About WeRideWeRide is a global leader and a first mover in the autonomous driving industry,...

RADNOR, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) — Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone, announced today the pricing of an upsized underwritten public offering of 9,803,921 shares of its common stock at a public offering price of $25.50 per share. The aggregate gross proceeds to Mineralys from the offering, before deducting underwriting discounts and commissions and other estimated offering expenses, are expected to be approximately $250.0 million. In addition, Mineralys has granted the underwriters a 30-day option to purchase up to an additional 1,470,588 shares of its common stock....

NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) — Royalty Pharma plc (Nasdaq: RPRX) announced today that it has priced an offering of $2.0 billion of senior unsecured notes, comprised of the following (collectively, the “Notes”):$600 million of 4.450% Notes due 2031 (the “2031 Notes”); $900 million of 5.200% Notes due 2035 (the “2035 Notes”); and $500 million of 5.950% Notes due 2055 (the “2055 Notes”).The Notes will be guaranteed on a senior unsecured basis by Royalty Pharma Holdings Ltd and Royalty Pharma Manager, LLC. The offering is expected to close on September 16, 2025, subject to the satisfaction of customary closing conditions. Royalty Pharma intends to use the net proceeds from the Notes for general corporate purposes. BofA Securities, Goldman Sachs & Co. LLC, J.P. Morgan, Morgan Stanley and TD Securities are acting...